Product NDC: | 0065-0795 |
Proprietary Name: | BSS |
Non Proprietary Name: | balanced salt solution |
Active Ingredient(s): | .48; .3; .75; 3.9; 6.4; 1.7 mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL & nbsp; balanced salt solution |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0065-0795 |
Labeler Name: | Alcon Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020742 |
Marketing Category: | NDA |
Start Marketing Date: | 19690328 |
Package NDC: | 0065-0795-15 |
Package Description: | 15 mL in 1 BOTTLE (0065-0795-15) |
NDC Code | 0065-0795-15 |
Proprietary Name | BSS |
Package Description | 15 mL in 1 BOTTLE (0065-0795-15) |
Product NDC | 0065-0795 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | balanced salt solution |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 19690328 |
Marketing Category Name | NDA |
Labeler Name | Alcon Laboratories, Inc. |
Substance Name | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE |
Strength Number | .48; .3; .75; 3.9; 6.4; 1.7 |
Strength Unit | mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL |
Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |